Home›Stock Screener›Hikal›Quarterly Results

Hikal Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹14 Cr
QMar 2026
Quarterly Results

In Mar 2026, Hikal (HIKAL) reported revenue ₹524 Cr and net profit ₹14 Cr — revenue -4.9% YoY. For annual financials, live price and key ratios, visit Hikal share price screener.

HIKAL Quarterly Results — Revenue, Profit & EPS Highlights

Hikal latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View HIKAL price range for the annual high/low range and current price position.

  • Revenue of ₹524 Cr in Mar 2026 (+27.5% vs Jun 2026, -4.9% vs Mar 2025)
  • Net Profit of ₹14 Cr in Mar 2026 (+300.0% vs Jun 2026, -72.0% vs Mar 2025)
  • EBITDA of ₹63 Cr in Mar 2026 (+40.0% vs Jun 2026)
  • Operating Margin of 11.0% in Mar 2026 (+2.0pp vs Jun 2026)
  • Earnings Per Share of ₹1.17 in Mar 2026 (+295.0% vs Jun 2026)

Hikal Quarterly Results — Revenue, EBITDA, Net Profit & EPS

HIKAL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 524 411 318 551 372 27.5% -4.9%
Net Profit (₹ Cr) 14 -7 -35 50 -22 - -
EBITDA (₹ Cr) 63 45 7 122 17 - -
EPS (₹) 1.17 -0.60 -2.83 4.07 -1.82 - -
Operating Margin (%) 11.0% 9.0% 2.0% 22.0% 4.0% - -

HIKAL Share Price Trend — 1-Year Movement Across Quarterly Results

Hikal 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse HIKAL FII DII holdings to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 2.7%
EBITDA Margin 12.0%
Operating Margin 11.0%
ROE (Annual) 4.7%

Balance Sheet Highlights

Total Assets ₹2,365 Cr
Total Equity ₹1,199 Cr
Current Assets ₹884 Cr
Current Liabilities ₹488 Cr

Cash Flow Analysis

Operating Cash Flow ₹302 Cr
Investing Cash Flow ₹-145 Cr
Financing Cash Flow ₹-160 Cr
Net Cash Flow ₹-3 Cr

Current Market Data

Current Price ₹226.04
Exchange NSE
Last Updated Sep 18, 2026

Revenue Trend (₹ Cr)

Mar 2025 551
Sept 2025 318
Jun 2026 411
Mar 2026 524

Net Profit Trend (₹ Cr)

Mar 2025 50
Sept 2025 -35
Jun 2026 -7
Mar 2026 14

Operating Margin Trend (%)

Mar 2025 22.0%
Sept 2025 2.0%
Jun 2026 9.0%
Mar 2026 11.0%

HIKAL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Hikal latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹441,477.63 Cr 1837.3 15,018 2,710 -5.6% - 18.0% 162.6
Divis Laboratories
Mar 2026 		₹247,469.81 Cr 9375.0 2,986 751 -5.0% - 25.2% 331.2
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4840.0 4,111 364 +27.7% +42.2% 8.9% 420.5
Cipla
Mar 2026 		₹112,654.03 Cr 1394.5 6,612 543 -9.3% - 8.2% 203.0
Zydus Life Science
Mar 2026 		₹112,607.65 Cr 1160.0 7,569 1,341 -4.3% - 17.7% 91.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores